Results & timelines
How long does a GLP-1 take to work?
October 2, 2026 · 6 min read · Medically reviewed by Bryan Milton, MD · Reviewed October 2, 2026
Appetite effects often appear within the first weeks, while the dose is still being titrated. What governs the timeline, and why no one can give you a date.
This is the most-asked question and the one with the least satisfying honest answer. Something usually happens early — most people notice appetite changes in the first weeks — but the medication is working through a titration schedule that takes weeks by design, and what follows varies enough that a date would be fiction.
What happens first?
The effects people describe earliest are the mechanical ones: feeling full sooner, staying full longer, less interest in food, and for many people a quieting of the background preoccupation with eating that is often called food noise. Those are consistent with what the medication does — slowing gastric emptying and acting on appetite signalling — and they can appear at a starting dose.
Why the first month is not the test
Because the approved labels describe the starting dose as a dose to let the body adjust, not a treatment dose. Semaglutide injections begin at 0.25 mg weekly; tirzepatide at 2.5 mg weekly. Both step up at intervals of at least four weeks. By design, the first month is about whether you tolerate the medication, not about what it ultimately does.
That is also why the first month is the one with the most side effects, which makes it a misleading sample in both directions.
So what should I expect, and when?
GLP does not publish expected results. The figures in circulation come from trials of the FDA-approved products on their approved schedules, averaged across thousands of participants — they do not describe a compounded preparation, a lower dose, or you. A service that tells you what you will achieve is telling you something it cannot know.
What is reasonable to describe is the shape:
| Stage | What is usually happening |
|---|---|
| First days | Possible appetite change; possible early nausea; sometimes nothing noticeable |
| First four weeks | Tolerability is the question; the dose is a starting dose |
| Each step up | A smaller repeat of the early side-effect pattern |
| Over months | The dose settles where your clinician holds it, and the trend becomes readable |
| Ongoing | Reviewed at check-ins against what treatment is for |
What makes it slower or faster?
- How your titration goes. Someone who tolerates each step moves up faster than someone who holds at one.
- The dose your clinician settles on, which is the lowest that is working rather than the highest available.
- What you do alongside it: protein, resistance training, sleep, and the eating patterns you build.
- Your own physiology, which is the variable nobody can see in advance.
- Whether anything else is going on — other medications, thyroid or hormonal conditions, sleep problems.
When should I ask whether it is working?
At your check-ins, which is what they are for. If you have been on a dose your clinician considers adequate for a reasonable stretch and nothing is happening, that is a finding — and the response is clinical: review the dose, review what else is going on, or reconsider whether this medication suits you. Not responding is a real outcome and it is information, not failure.
What is not useful is daily weighing in the first month. It measures fluid and timing, not progress, and it makes a noisy signal feel like a verdict.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.